{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:03:24Z","timestamp":1792098204069,"version":"4.4.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.humpath.2011.03.003","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T23:17:46Z","timestamp":1308957466000},"page":"918-931","source":"Crossref","is-referenced-by-count":918,"title":["Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014Shifting the paradigm"],"prefix":"10.1016","volume":"42","author":[{"given":"Robert J.","family":"Kurman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ie-Ming","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2011.03.003_bb0005","series-title":"University of Chicago Press","article-title":"The structure of scientific revolutions, 3rd ed., enlarged","author":"Kuhn","year":"1996"},{"key":"10.1016\/j.humpath.2011.03.003_bb0010","series-title":"Ovarian tumors","author":"Geist","year":"1942"},{"key":"10.1016\/j.humpath.2011.03.003_bb0015","series-title":"Gynecological and obstetrical pathology","author":"Frank","year":"1931"},{"key":"10.1016\/j.humpath.2011.03.003_bb0020","series-title":"Atlas of ovarian tumors","author":"Gemma","year":"1943"},{"key":"10.1016\/j.humpath.2011.03.003_bb0025","series-title":"Atlas of tumor pathology. Section ix\u2013fascicle 3: tumors of the female sex organs. Part 3: tumors of the ovary and fallopian tube","author":"Hertig","year":"1961"},{"key":"10.1016\/j.humpath.2011.03.003_bb0030","series-title":"International Histological Classification of Tumours no. 9. Histological typing of ovarian tunours","author":"Serov","year":"1973"},{"issue":"Suppl 2","key":"10.1016\/j.humpath.2011.03.003_bb0035","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1038\/modpathol.3800306","article-title":"Origins and molecular pathology of ovarian cancer","volume":"18","author":"Bell","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0040","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L","article-title":"Early de novo ovarian carcinoma. A study of fourteen cases","volume":"73","author":"Bell","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2011.03.003_bb0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2009.03.023","article-title":"Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity","volume":"114","author":"Cai","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1525-1438.1997.00379.x","article-title":"Ovarian dysplasia: a review","volume":"7","author":"Deligdisch","year":"1997","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.humpath.2011.03.003_bb0055","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.0.CO;2-I","article-title":"Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations","volume":"86","author":"Deligdisch","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2011.03.003_bb0060","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/jnci\/88.24.1810","article-title":"Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies","volume":"88","author":"Salazar","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2011.03.003_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0046-8177(99)90269-1","article-title":"Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer","volume":"30","author":"Werness","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00004347-199904000-00009","article-title":"Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis","volume":"18","author":"Sherman","year":"1999","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/jnci\/91.7.626","article-title":"Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group","volume":"91","author":"Stratton","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2011.03.003_bb0080","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ygyno.2007.03.028","article-title":"Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma","volume":"106","author":"Seidman","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0085","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/cncr.10497","article-title":"Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity","volume":"94","author":"Yang","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2011.03.003_bb0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO;2-T","article-title":"Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes","volume":"89","author":"Barakat","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2011.03.003_bb0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/IGC.0b013e3181990127","article-title":"Ovarian epithelial dysplasia and prophylactic oophorectomy for genetic risk","volume":"19","author":"Chene","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.humpath.2011.03.003_bb0100","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00000478-199611000-00003","article-title":"Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors","volume":"20","author":"Burks","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0105","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis- a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0110","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.humpath.2011.03.003_bb0115","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2011.03.003_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0125","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ygyno.2010.07.026","article-title":"A critical re-appraisal of BRCA1 methylation studies in ovarian cancer","volume":"119","author":"Senturk","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2010.01.006","article-title":"Low malignant potential tumors with micropapillary features are molecularly similar to low grade serous carcinoma of the ovary","volume":"117","author":"May","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0135","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/sj.onc.1208298","article-title":"Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential","volume":"24","author":"Meinhold-Heerlein","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2011.03.003_bb0140","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1158\/0008-5472.CAN-05-2240","article-title":"Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary","volume":"65","author":"Bonome","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.03.003_bb0145","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ygyno.2004.11.039","article-title":"Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling","volume":"96","author":"Gilks","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0150","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/PAS.0b013e31802cbbe9","article-title":"The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis","volume":"31","author":"Dehari","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0155","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2011.03.003_bb0160","first-page":"1489","article-title":"Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy","volume":"53","author":"Mok","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.03.003_bb0165","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.1521","article-title":"In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours","volume":"202","author":"Sieben","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0170","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ygyno.2006.05.029","article-title":"KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants","volume":"103","author":"Mayr","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2006.05.023","article-title":"HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors","volume":"10","author":"Wang","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2011.03.003_bb0180","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4161\/cbt.5.7.2751","article-title":"Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms","volume":"5","author":"Nakayama","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.humpath.2011.03.003_bb0185","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1158\/1078-0432.CCR-04-0893","article-title":"Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas","volume":"10","author":"Hsu","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2011.03.003_bb0190","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1158\/0008-5472.CAN-04-2067","article-title":"Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors","volume":"64","author":"Ho","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.03.003_bb0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/hupa.2002.30212","article-title":"Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas","volume":"33","author":"Staebler","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0200","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/ijc.22609","article-title":"Amplicon profiles in ovarian serous carcinomas","volume":"120","author":"Nakayama","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2011.03.003_bb0205","first-page":"e1","article-title":"Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis","volume":"584","author":"Shih Ie","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0210","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1158\/0008-5472.CAN-04-2933","article-title":"Mutation of the PIK3CA gene in ovarian and breast cancer","volume":"64","author":"Campbell","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.03.003_bb0215","first-page":"7052","article-title":"Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary","volume":"60","author":"Sato","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.03.003_bb0220","first-page":"2095","article-title":"Frequent PTEN\/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors","volume":"58","author":"Obata","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.03.003_bb0225","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.humpath.2004.07.019","article-title":"Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas","volume":"35","author":"Catasus","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"Ovarian cancer","volume":"4","author":"Cho","year":"2009","journal-title":"Ann Rev Pathol Mech Dis"},{"key":"10.1016\/j.humpath.2011.03.003_bb0235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccr.2007.02.016","article-title":"Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt\/B-catenin and PI3K\/Pten signaling pathways","volume":"11","author":"Wu","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2011.03.003_bb0240","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.humpath.2006.10.007","article-title":"Alternate molecular genetic pathways in ovarian carcinomas of common histological types","volume":"38","author":"Willner","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0245","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9440(10)65148-6","article-title":"Beta-catenin expression pattern in stage I and II ovarian carcinomas: relationship with beta-catenin gene: mutations, clinicopathological features, and clinical outcome","volume":"155","author":"Gamallo","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/path.856","article-title":"Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation","volume":"194","author":"Saegusa","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0255","first-page":"1707","article-title":"Allelo typing of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage","volume":"58","author":"Jiang","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.03.003_bb0260","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","article-title":"Telomere length in different histologic types of epithelial ovarian carcinoma with emphasis on clear cell carcinoma","volume":"34","author":"Kuhn","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0265","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/1097-0142(19880115)61:2<340::AID-CNCR2820610225>3.0.CO;2-U","article-title":"Ovarian M\u00fcllerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis","volume":"61","author":"Rutgers","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2011.03.003_bb0270","first-page":"33","article-title":"Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors","volume":"54","author":"Ichikawa","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.03.003_bb0275","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0090-8258(03)00264-6","article-title":"Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma","volume":"90","author":"Gemignani","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0280","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0285","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(01)05992-X","article-title":"Tubal ligation and risk of ovarian cancer","volume":"358","author":"Piek","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2011.03.003_bb0290","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0090-8258(03)00365-2","article-title":"BRCA1\/2-related ovarian cancers are of tubal origin: a hypothesis","volume":"90","author":"Piek","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0295","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0300","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.pgp.0000101082.35393.84","article-title":"Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers","volume":"23","author":"Carcangiu","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0305","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","article-title":"Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis","volume":"80","author":"Paley","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0310","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0315","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0320","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0325","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0330","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0335","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0340","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0345","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","article-title":"Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon","volume":"11","author":"Marquez","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2011.03.003_bb0350","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0355","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/modpathol.2010.60","article-title":"Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase","volume":"23","author":"Smith Sedhev","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0360","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","article-title":"Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis","volume":"34","author":"Kuhn","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0365","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(07)60534-0","article-title":"Ovarian cancer and hormone replacement therapy in the Million Women Study","volume":"369","author":"Beral","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2011.03.003_bb0370","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/oxfordjournals.aje.a113523","article-title":"Events of reproductive life and the incidence of epithelial ovarian cancer","volume":"117","author":"Risch","year":"1983","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0375","doi-asserted-by":"crossref","first-page":"e10358","DOI":"10.1371\/journal.pone.0010358","article-title":"Genetic analysis of the early natural history of epithelial ovarian carcinoma","volume":"5","author":"Pothuri","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2011.03.003_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0385","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/PAS.0b013e31819c4271","article-title":"Cystic and adeno\ufb01bromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases","volume":"33","author":"Veras","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0390","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1056\/NEJMra0804690","article-title":"Endometriosis","volume":"360","author":"Bulun","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2011.03.003_bb0395","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-2008-1068762","article-title":"Cancer and endometriosis: do we need to be concerned?","volume":"15","author":"Martin","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0400","first-page":"933","article-title":"Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives","volume":"5","author":"Rosenblatt","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.humpath.2011.03.003_bb0405","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00000478-199906000-00001","article-title":"Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, and metastatic carcinomas","volume":"23","author":"Riopel","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0410","series-title":"Blaustein's pathology of the female genital tract","first-page":"679","article-title":"Surface epithelial tumors of the ovary","author":"Seidman","year":"2011"},{"key":"10.1016\/j.humpath.2011.03.003_bb0415","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.5858\/132.11.1753","article-title":"Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors","volume":"132","author":"Seidman","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2011.03.003_bb0420","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/PGP.0b013e3181f29d2a","article-title":"The fallopian tube\u2013peritoneal junction: a potential site of carcinogenesis","volume":"30","author":"Seidman","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0425","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/PAS.0b013e31802efb45","article-title":"Ovarian mucinous tumors associated with mature cystic teratomas. Morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered in the ovary","volume":"31","author":"Vang","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0430","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006254-196104000-00022","article-title":"Primary carcinoma of the fallopian tube","volume":"16","author":"Sedlis","year":"1961","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.humpath.2011.03.003_bb0435","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/cncr.22919","article-title":"Metastatic patterns at autopsy in patients with ovarian carcinoma","volume":"110","author":"Guth","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2011.03.003_bb0440","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/IGC.0b013e318199009c","article-title":"The fallopian tube: primary site of most pelvic high-grade serous carcinomas","volume":"19","author":"Salvador","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.humpath.2011.03.003_bb0445","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/AOG.0b013e31819cda77","article-title":"Results from four rounds of ovarian cancer screening in a randomized trial","volume":"113","author":"Partridge","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0450","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/PGP.0b013e3181c713a8","article-title":"Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications","volume":"29","author":"Carlson","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0455","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/jnci\/djq509","article-title":"Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2","volume":"103","author":"Drew","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2011.03.003_bb0460","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(10)60893-8","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial","volume":"376","author":"Audeh","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2011.03.003_bb0465","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(10)60892-6","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial","volume":"376","author":"Tutt","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2011.03.003_bb0470","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1200\/JCO.2009.27.5719","article-title":"Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer","volume":"28","author":"Konstantinopoulos","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0475","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-1-60327-492-0_20","article-title":"Epidemiology of ovarian cancer","volume":"472","author":"Permuth-Wey","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.humpath.2011.03.003_bb0480","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711001377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711001377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T13:20:39Z","timestamp":1637932839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817711001377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":96,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0046817711001377"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2011.03.003","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}